CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Cash flows from operating activities
Net loss	$ (305,641)	$ (4,078,366)	$ (5,489,892)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	(41,458)	(31,528)
Provision for employee advance reserve	(1,714)
Depreciation and amortization	41,621	35,846
Stock-based compensation	162,763	330,021
Warrants issued to 2012 private placement investors		487,200
Loss on extinguishment of notes and accounts payable		2,792,900
Imputed value of services contributed	87,500	87,500
Amortization of debt discount	54,035	44,363
Changes in operating assets and liabilities:
Accounts receivable	273,902	(6,238)
Inventories - finished goods	31,149	85,519
Prepaid expenses and other current assets	18,531	10,451
Accounts payable - trade	(383,331)	(91,216)
Accounts payable - related parties	(5,445)	185,999
Accrued expenses and other current liabilities	25,172	(340,265)
Deferred revenue	(17,002)	30,441
Net cash used in operating activities	(59,918)	(457,373)	(1,024,781)
Cash flows from investing activities
Change in restricted cash		725,002
Website development costs	(34,866)	(25,490)
Net cash (used in) and provided by investing activities	(34,866)	699,512
Cash flows from financing activities
Principal payments on equipment leases payable	(13,159)	(11,759)
Proceeds from issuance of notes payable	100,000	500,000
Repayment of notes payable		(2,000,000)
Repayment of convertible notes payable		(1,000,000)
Proceeds from the sale of common stock		2,526,973
Proceeds from offering prior to reaching minimum offering amount		125,000
Net cash provided by financing activities	86,841	140,214
(Net decrease) net increase in cash	(7,944)	382,353
Cash - beginning of period	67,744
Cash - end of period	59,800	382,353	67,744
Interest	25,523	367,978
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	279,380	261,084
Cashless exercise of warrants into common stock		6,934
Warrants issued as debt discount in connection with notes payable	26,000	315,300
Accrual of contractual dividends on Series B convertible preferred stock	74,730	69,840
Deemed dividends on Series B convertible preferred stock		1,532,722
Common stock and warrants issued in exchange of notes and accounts payable		3,625,900
Conversion of accounts payable to notes payable		$ 40,000